1 Simon DR, Palese MA. Clinical update on the management of adrenal hemorrhage. Curr Urol Rep. 2009;10:78–83.
2 Marti JL, Millet J, Sosa JA, Roman SA, Carling T, Udelsman R. Spontaneous adrenal hemorrhage with associated masses: etiology and management in 6 cases and a review of 133 reported cases. Word J Surg. 2011;36:75–82.
3 Vella A, Nippoldt TB, Moris JC. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Myo Clin Proc. 2001;76:161–8.
4 Rossi GP, Bolognesi M, Rizzonie D, Seccia TM, Piva A, Porteri E, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients.
Hypertension. 2008;51:1366–71.
5 Kovac K, Lam YM, Pater JL. Bilateral massive adrenal hemorrhage, Assessment of putative risk factors by the case-control method. Medicine. 2001;80:45–53.
6 Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrine Metab. 2008;93(9):3266–81.
7 Vin-Cent W, Shuo-Meng W, Chia-Hiu C, Ya-Hui H, Lian-Yu L, et al. Long term outcome of aldosteronism after target treatments.
Sci Rep. 2016;2;6:32103.
8 Füessl HS. Fortbildung Notfallcheckliste. MMW Fortschr Med. 2015;157(6):48–9.